“…In addition, it possesses immunodominant, linear, cross-reactive epitopes in the N-terminal region (Elgh et al, 1996b;Gott et al, 1997;Jenison et al, 1994;Wang et al, 1993;Yamada et al, 1995). In order to provide large quantities of pure antigen for diagnostic purposes, the ATS peptide was introduced into N-terminal parts of HTNV-N and SEOV-N (1-70 amino acids residues of N) by recombinant DNA technology (Fig.…”